Abstract:Aprotinin is a 58 amino acid bovine protease inhibitor which inhibits a range of serine proteases including trypsin,chymotrypsin,plasmin,kallikrein and trombin.This single-chain polypeptide with the molecular mass of 6.5 kDa and the PI of 10.5 is crosslinked by three disulphide-bond bridges.It was initially isolated from bovine pancreas by Kunitz and Northrop.Aprotinin has been widely used in various fields.It can be used as inhibitor in protein purification procedure and tissue culture to prevent the degradation.In clinical use,because of its antifibrinolytic properties,aprotinin can be used in cardiac surgery to decrease postoperative blood loss and preserve platelet function during cardiopulmonary bypass.Due to the large requirement of aprotinin,the methods to produce aprotinin with high homogeneity and yields have been studied.Most of the reports regarding this topic are about purification of aprotinin from bovine tissues.But these purification procedures are complicated and costly.So the development of effective recombinant expression system is necessary.In this study,the deoxyoligonucleotide encoding aprotinin was synthesized according to the codon prefernce of E.coli.The DNA sequence was amplified by PCR and inserted into the expression vector pET28a between the NdeI and XhoI sites.The recombinant expression plasmid was then transformed into E.coli strain Rosetta(DE3),and recombinant aprotinin(r-aprotinin) was expressed as inclusion body by IPTG induction.The amount of r-aprotinin expressed accounted for 8%～10% of the total bacterial protein.After purification of inclusion body,renaturation and CM cation-exchange chromatography,2.4 mg r-aprotinin was obtained from one liter of shaking flask culture of E.coli with homogeneity greater than 90%.Kinetic studies demonstrated that r-aprotinin competitively inhibited the amidolytic activity of plsamin against small substrate S2251. The inhibition constant(Ki) was(0.6±0.3) nmol/L,which was similar to that of the native aprotinin.

Study on Expression,renaturation and Purification of Reteplase

Heterologous expression, purification and single step efficient refolding of recombinant tissue plasminogen activator (Reteplase) from E. coli

Expression of Activity Reteplase in E.coli

Preparation of R- ETI Affinity Chromatograpy Media and Its Application on Purification of Reteplase

The Secretive Expression of Reteplase in Pichia Pastoris and Optimization of Its Fermentation Conditions

Research on Reteplase Renaturation in Vitro

Soluble Expression of Reteplase in E.coli Induced by Lactose

Expression of the Recombinant Plasminogen Activator (rpa) and Its Mutants

Expression of rPA(K)in Prokaryotic System and The Preliminary Purification of Its Product

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Preparation and characterization of scFv for affinity purification of reteplase.

Expression of Reteplase in Lactococcus lactis

Expression of Reteplase in Recombinant Pichia Pastoris

High-level Expression,Purification and Activity of the Plectasin

Renaturation, Purification, and Characterization of Human Plasminogen Activator Inhibitor Type 2 (Pai-2) Accumulated at High Level in Escherichia Coli

Studies on Inclusion Body Purification and Denaturation of Reteplase

Study on Cloning, Expression and Function of Recombinant Human Plasminogen Serine Protease Activating Region Gene

Expression of Recombinant Aprotinin in E.coli and the Identification of Its Biological Activity

High Efficient Expression and Purification of the Escherichia Coli T-protein

An Efficient System for Production of Recombinant Urokinase-Type Plasminogen Activator.

Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli